My Cart

LIF R

LIF R Overview

English NameLeukemia inhibitory factor receptorApproved Drugs0
Drugs in Clinical Trials2Target SynonymLIF receptor,LIF-R,CD118
Highest Development StagePhase 2 Clinical
English NameLeukemia inhibitory factor receptor
Target SynonymLIF receptor,LIF-R,CD118
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

LIF R Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Fc Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
LIR-H4252
Human
HEK293
Human LIF R / CD118 Protein, Fc Tag
Add to Cart
Total: 1
  • 1

LIF R Background

Leukemia inhibitory factor receptor is also known as LIFR; CD118; FLJ98106; FLJ99923; LIF-R; SJS2; STWS; SWS, is the receptor for leukemia inhibitory factor (LIF). The leukemia inhibitory factor is a polyfunctional cytokine that affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIF action appears to be mediated through a high-affinity receptor complex composed of a low-affinity LIF binding chain (LIF receptor) and a high-affinity converter subunit, gp130. Both LIFR and gp130 are members of a family of cytokine receptors that includes components of the receptors for the majority of hematopoietic cytokines and for cytokines that affect other systems, including the ciliary neurotrophic factor, growth hormone and prolactin Defects in LIFR are the cause of Stueve-Wiedemann syndrome (SWS), a severe autosomal recessive condition and belongs to the group of the bent-bone dysplasias.

LIF R Synonyms

LIFR,CD118,FLJ98106,FLJ99923,SJS2,STWS,SWS

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Cardiotrophin-1 (Digna Biotech/Biotecnol)CT-1Phase 2 ClinicalBiotecnol Sa, Digna Biotech Sl, Genentech IncAcute Kidney Injury; Ischemia; Liver Failure; Myocardial Reperfusion Injury
Details
MSC-1 (Northern Biologics)Phase 1 ClinicalMosaic BiosciencesCarcinoma, Non-Small-Cell Lung; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information